Recombinant Ricin Toxin Binding Subunit B (RTB) Stimulates Production of TNF- by Mouse Macrophages Through Activation of TLR4 Signaling Pathway

Na Xu,Kaikai Yu,Haotian Yu,Jianxu Zhang,Yang Yang,Mingxin Dong,Yan Wang,Ying Chang,Yucheng Sun,Yanguang Hou,Chengbiao Sun,Jiayu Wan,Wensen Liu
DOI: https://doi.org/10.3389/fphar.2020.526129
IF: 5.6
2020-01-01
Frontiers in Pharmacology
Abstract:Ricin toxin binding subunit B (RTB) is a galactose-binding lectin protein derived from the beans of the castor oil plant (Ricinus communis). Our previous studies have reported a direct immunomodulatory effect of recombinant RTB, which stimulates RAW264.7 cells to produce cytokines including TNF-alpha. However, the role of RTB in innate immune response and its specific mechanism have not been reported in detail. In this work, the results showed that RTB treatment of macrophages significantly increased TLR4 protein levels. RTB also activated TLR4 downstream events, including MyD88, IRAK, and TRAF6, resulting in macrophage activation and TNF-alpha production. This process is reflected in the increase of I kappa B phosphorylation. TLR4 knockdown macrophages treated with RTB exhibited greatly reduced I kappa B phosphorylation and TNF-alpha secretion. Moreover, treatment with MyD88 inhibitor also suppressed TNF-alpha production. The docking of RT and TLR4 was simulated by computer, and the contact residues were concentrated on RTB. Our results suggest that recombinant RTB can activate mouse macrophages to secrete TNF-alpha through activation of NF-kappa Bviathe TLR4 signaling pathways.
What problem does this paper attempt to address?